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Previously, we reported that ovariectomy (OVX) combined with b-amyloid peptide (Ab) impaired spatial
memory by decreasing extracellular acetylcholine (ACh) levels in the dorsal hippocampus. Here, we
investigated the effect of tokishakuyakusan (TSS), a Kampo medicine, on the impairment of spatial
memory induced by OVX combined with Ab in rats. Repeated administration of TSS (300 mg/kg, p.o.)
signiﬁcantly decreased the number of errors in the eight-arm radial maze test. Though TSS had no effect
on extracellular ACh levels at baseline, TSS signiﬁcantly increased extracellular ACh levels in the dorsal
hippocampus. These results suggest that TSS improves the impairment of spatial memory induced by
OVX combined with Ab by (at least in part) increasing extracellular ACh levels in the dorsal hippocampus.
© 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Alzheimer's disease (AD) is characterized by: clinical evidence of
cognitive failure in association with cerebral amyloidosis; cerebral
intraneuronal neuroﬁbrillary disease; neuronal and synaptic loss;
and neurotransmitter deﬁcits.1 b-Amyloid peptide (Ab) aggregate is
one of the major constituents of the senile plaques in the brain
regions serving memory and cognition, and plays a causative part
in the neuronal degeneration and memory loss seen in AD
patients.2 In transgenic mice, a 14-fold increase in Ab(1e42/43) has
been reported to accompany the appearance of behavioral deﬁcits.3
Moreover, Ab1e42 is neurotoxic,4 and intracerebroventricular
infusion of Ab1e42 impairs learning and memory deﬁcits in rats.5
AD burden falls more heavily on women than men. It has been
hypothesized that plummeting levels of circulating estrogens after(NMM) with signiﬁcant bio-
gy.
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d/4.0/).the menopause increase a woman's risk for this disorder.6 In ani-
mals, prolonged ovariectomy (OVX) has been shown to result in
uterine atrophy and reduced serum levels of 17b-estradiol, and to
be associatedwith a pronounced increase in brain levels of Ab. Total
brain Ab in ovariectomized (OVX) guinea pigs has been shown to
increase by 1.5-fold on average as compared with intact controls.7
Yamada et al.8 reported Ab-induced working memory deﬁcits to
be potentiated signiﬁcantly in OVX rats compared with sham-
operated rats. We also investigated the effects of OVX and Ab1e42,
separately and in combination, on performance in the radial arm
maze. We found that OVX combined with Ab impaired spatial
memory by decreasing extracellular acetylcholine (ACh) levels and
alpha7 nicotinic acetylcholine receptor expression without
inducing apoptosis in the dorsal hippocampus.9 Thus, OVX seems to
potentiate the Ab-induced impairment of spatial memory and
neurotransmitter in rats.
Decades ago, postmenopausal hormone replacement was
considered a panacea for middle-aged women. Prevention of age-
related cognitive decline was among the major alleged beneﬁts of
this therapy. However, a recent systematic review and prospective
cohort study showed that postmenopausal hormone therapy is not
associated with a risk of all-cause dementia or AD.10,11nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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traditionalmedicines. TSS has been used for the treatment ofmainly
gynecologic symptoms and cognitive disorders in elderly women
due to its estrogen-secreting qualities. TSS can be recommended
as anti-dysmenorrhea therapy for women with endometriosis or
adenomyosis who wish to become pregnant.12 TSS has also been
used in AD treatment, especially in postmenopausal women.13 We
have reported that TSS: improves scopolamine-induced impairment
of spatial memory in rats14; protects Ab25e35-induced neuronal
damage and lipid peroxidation in cultured rat cortical neurons15;
prevents impairment of spatial memory induced by repeated cere-
bral ischemia in rats.16 However, the effect of TSS on the impairment
of spatial memory induced by OVX combined with Ab has not been
explored.
The present study was conducted to investigate the effect of TSS
on the impairment of spatial memory induced by OVX combined
with Ab in rats. We also investigated the effects of TSS on extra-
cellular ACh levels in the dorsal hippocampus, which is an impor-
tant brain site with regard to spatial memory.Materials and methods
Animals
Experiments were undertaken on 110 female Wistar rats
(230e270 g; Kyudo, Tosu, Japan). Rats were housed in groups of 5
per cage (30  35  17 cm) in a roomwith controlled temperature
(23 ± 2 C), relative humidity (60 ± 2%) and a 12-h lightedark cycle
with the light period starting at 7 am. Animals scheduled to un-
dergo the eight-arm radial maze test (8ARMT) were placed on
restricted (10e12 g per day) food (CE-2; Clea Japan, Tokyo, Japan)
intake and maintained at z80% of their free-feeding body weight
(which was determined during the experimental period). All ani-
mals had free access to drinking water in their home cages. All
animal care and use procedures were performed in compliance
with the regulations established by the Experimental Animal Care
and Use Committee of Fukuoka University followed the Guidelines
of the Science Council of Japan (approved no. 205460 of institu-
tional review board).
OVX. Rats were anesthetized with halothane (Takeda Chemical
Industries, Osaka, Japan) using a small animal anesthetizer (TK-4;
Bio Machinery, Tokyo, Japan) and laid on a ventral surface with the
tail pointing towards the experimenter. The skinwas incised (2 cm)
midline halfway between the hump and base of the tail, and
retracted to the side where the ovary was to be removed. The
abdominal muscle two-thirds of the way down the side was
incised. The ovary was pulled out through the muscle incision by
grasping the periovarian fat and removed.17 An identical procedure
was done on the other side to remove the other ovary. These rats
were referred to as “OVX rats”. Rats subjected to the same pro-
cedure but where only skin and muscles were cut, but the ovaries
were spared, were referred to as “sham rats”.
8ARMT. The behavioral experiment was started on postoperative
day (POD)1. The behavioral testing was conducted as reported pre-
viously9 using a modiﬁed version of the 8ARMT (Neuroscience,
Tokyo, Japan) of the original maze developed by Olton and
Samuelson.18 The trial continued until the rat had entered all eight-
arms or 10 min had elapsed.
The performance of each animal in every trial was assessed
using three parameters: (i) the number of correct choices in the
initial eight chosen arms; (ii) the number of errors deﬁned by
choosing arms that had been visited already; (iii) the time elapsed
before the animal consumed all eight pellets. One training trial was
given per day, Monday to Saturday. Only the rats that made noerrors, or only one error for 3 consecutive days, were selected for
the study.
Stereotaxic procedure. Rats were anesthetized (sodium
pentobarbital, 50 mg/kg, i.p.; Tokyo Kasei, Tokyo, Japan) and placed
in a stereotaxic frame (Narishige Scientiﬁc Instruments, Tokyo,
Japan) with the upper incisor bar 3.4-mm below the level of the
interaural line. Guide cannulae were implanted according to the
stereotaxic coordinates employed by Paxinos and Watson.19
In microdialysis studies, guide cannulae (length ¼ 13 mm; outer
diameter (o.d.)¼ 0.85 mm; inner diameter (i.d.)¼ 0.75 mm; Eicom,
Kyoto, Japan) were implanted into the dorsal hippocampus at the
following coordinates (mm): anteroposterior (AP) ¼ 4.0 posterior
to the bregma; lateral (L) ¼ 3.3 from the midsagittal line; dorso-
ventral (DV) ¼ 1.8 relative to the skull surface. For intra-
cerebroventricular infusion, guide cannulae (o.d.¼ 0.71± 0.02mm;
i.d. ¼ 0.41 ± 0.02 mm; length ¼ 13 mm) were implanted bilaterally
into the lateral cerebral ventricles at AP ¼0.8, L¼ 1.3 and H ¼ 3.3.
Drugs and experimental paradigm. Ab1e42 HCl (Anaspec, San
Jose, CA, USA) was dissolved in sterile distilledwater, and allowed to
aggregate for 7 days at 37 C. Ab1e42 was injected once daily for 7
days starting 3weeks after OVX. Ab1e42 was administered bilaterally
(300 pmoL/10 mL) using an injection cannula (o.d.¼ 0.35± 0.01mm;
i.d. ¼ 0.17 ± 0.02 mm; length ¼ 14 mm) connected by polyethylene
tubing (o.d. ¼ 1.09 mm; i.d. ¼ 0.38 mm; Intramedic; Becton Dick-
inson, Franklin Lakes, NJ, USA) to a perfusion pump (CMA/100;
Microdialysis, Stockholm, Sweden) driven at a rate of 1 mL/min.
TSS (Lot. No. 2010023010) was a generous gift from Tsumura &
Co (Tokyo). TSS was a dried extract of the following raw materials:
Alismatis tuber (Alismataceae, Alisma orientale Juzepczuk, 4.0 g),
Angelicae acutilobae radix (Umbelliferae, Angelica acutiloba Kita-
gawa, 3.0 g), Atractylodis lanceae rhizoma (Composite, Atractylodes
lancea De Candolle, 4.0 g), Cnidii rhizoma (Umbelliferae, Cnidium
ofﬁcinale Makino, 3.0 g), Paeoniae radix (Paeoniaceae, Paeonia lac-
tiﬂora Pallas, 4.0 g), and Poria (Polyporaceae, Poria cocosWolf, 4.0 g).
Each plant material was authenticated by identiﬁcation of external
morphology and marker compounds of plants specimens, accord-
ing to the methods of the Japanese Pharmacopoeia and Tsumura &
Co's standard. The six medical herbs were extracted with puriﬁed
water at 95 C for 1 h, and the extraction solution was separated
from the insoluble waste and concentrated by removing water
under reduced pressure. Spray drying was used to produce a dried
extract powder. The yield of the extract was about 17.5%. They were
manufactured in compliance with the Japanese Pharmacopoeia
(Seventeenth Edition, JP17) under Good Manufacturing Practice
(GMP). The product information can be acquired in “KCONSORT”
(http://kconsort.umin.jp).
Donepezil hydrochloride (DPZ) was obtained from Eisai, Tokyo,
Japan. DPZ and TSS were dissolved in distilled water. TSS was orally
administered using a plastic syringe with a stainless-steel tube
immediately after injection of Ab1e42 for 7 days. DPZ was admin-
istered (p.o.) immediately before the last injection of Ab1e42. DPZ
and TSS doses were chosen based on reports.9,16,20 Control animals
received oral injections with the drug vehicle (distilled water). The
injection volume of vehicle, DPZ or TSS was 1 mL/kg. The 8ARMT
was carried out 60 min after the ﬁnal injection of Ab1e42. Different
groups were used in HPLC study. All experiments in this study were
carried out between 7 am and 7 pm.
Brain microdialysis. On day-7 of Ab injection, we carried out
brainmicrodialysis as described previously.9 On POD3, extracellular
levels of ACh were measured in the dorsal hippocampus of non-
anesthetized, freely moving rats by microdialysis. Dialyzate ali-
quots (20 mL) were collected every 20 min, injected directly into a
HPLC system and assayed further for ACh. After a settling period (at
least 2e3 h), samples were collected over a 40-min period (base-
line, BL-1 and BL-2) before Ab injection for the following 120 min.
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Fig. 1. Effects of DPZ on the impairment of spatial memory and decrease in extracel-
lular ACh levels induced by OVX combined with Ab (OVX þ Ab). Ab was injected once
daily for 7 days starting 3 weeks after OVX. DPZ (3 mg/kg, p.o.) was administered
immediately before the last injection of Ab. (a) The number of correct choices (open
bars) and errors (closed bars) in the eight-arm radial maze test. The eight-arm radial
maze test was carried out 60 min after the last injection of Ab. Values are the
mean ± SEM. *p < 0.05, ***p < 0.001 compared with sham, ##p < 0.01 compared with
vehicle (Scheffe's test). (b) Time-course of changes in extracellular ACh levels in di-
alyzates from the dorsal hippocampus of vehicle- and DPZ-treated OVX þ Ab rats.
Extracellular ACh levels were measured in the dorsal hippocampus of non-
anesthetized, freely moving rats by microdialysis on the seventh day. After a settling
period (at least 2e3 h), samples were collected over a 40-min period (baseline, BL-1
and BL-2) before Ab injection and for the following 120 min. Values are expressed
as percentages (mean ± SEM) of the baseline concentration (BL-1). ###p < 0.001
compared with vehicle (two-way repeated ANOVA).
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300; Eicom). ACh was separated on a reverse-phase analytical
column (Eicompak AC-GEL; 2.0∅  150 mm; Eicom). A guard (pre)
column (diameter ¼ 3.0 mm  4 mm with a CH-GEL ﬁlter; Eicom)
was placed before the analytical column external to the HPLC. An
enzyme column (AC-Enzympak; diameter ¼ 3.0 mm; Eicom) in
which acetylcholinesterase and choline oxidase were immobilized
on controlled-pore glass (diameter of pore and 200/400 mesh glass
beads ¼ 546 Å) was placed after the analytical column within the
HPLC system.
After its separation on the analytical column, ACh was hydro-
lyzed by acetylcholinesterase to acetate and choline in a post-
column enzyme reactor, and choline was oxidized by choline
oxidase to produce betaine and hydrogen peroxide. The analytical
and enzyme columns were maintained at 33 C by a column oven
(ATC-300; Eicom). Detection was undertaken using an electro-
chemical detector (ECD-300; Eicom) with a platinum electrode
(WE-PT) set at þ 450 mV vs. an Ag/AgCl reference electrode
(Ag/AgCl RE-100). The mobile phase (50 mM Na2HPO4.12H2O,
50 mM H3PO4, 1.23 mM sodium 1-decanesulfonate and 0.013 mM
EDTA2Na, pH 8.2) was degassed (DG-300; Eicom) and pumped at a
ﬂow rate of 0.15 mL/min. An internal standard (0.05 pmol/mL iso-
propylhemicholine) was injected simultaneously with the perfu-
sion Ringer solution into the autoinjector at a rate of 1 mL/min.
Peaks were recorded using a PowerChrom integrator (Eicom). To
evaluate the amount of ACh in the samples, a linear regression curve
was constructed for the standards (1 pmol of choline, iso-
propylhemicholine and ACh standards). The peak heights of ACh in
the samples were compared with the standards using a data pro-
cessor (EPC-300; Eicom). The limit of detection, based on the signal-
to-noise ratio, was 10 fmol ACh. TheHPLC standards, AChperchlorate
and choline ([2-Hydroxyethyl] trimethylammonium) were pur-
chased from SigmaeAldrich. Isopropylhomocholinewas fromEicom.
At the end of the experiment, the rats were decapitated. Their
brains were removed rapidly, sectioned at a thickness of 50 mm, and
placement of the microdialysis probes in the dorsal hippocampus
was veriﬁed.
Statistical analyses. 8ARMT results (number of correct choices
and errors) were evaluated for statistical signiﬁcance using a non-
parametric analysis of variance (KruskaleWallis test) followed by
the Scheffe's test. The data for running time and ACh levels at
baseline were evaluated for signiﬁcance using one-way ANOVA
followed by the TukeyeKramer post hoc test. Data for brain
microdialysis were expressed as percentages of the baseline
concentration, and were analyzed by two-way repeated ANOVA.
Data were analyzed using StatView J 5.0 (Abacus Concepts, Berke-
ley, CA, USA). The criterion for statistical signiﬁcance was consid-
ered to be p < 0.05. Values are the mean ± SEM.
Results
Effect of DPZ on the impairment of spatial memory induced by OVX
combined with Ab
OVX combined with Ab signiﬁcantly decreased the number of
correct choices [H2 ¼ 8.187, p < 0.05 by the KruskaleWallis test;
p < 0.05 by the Scheffe's test] and increased the number of errors
compared with the sham group [H2 ¼ 19.361, p < 0.0001 by the
KruskaleWallis test; p < 0.001 by the Scheffe's test], thereby indi-
cating impairment of spatial memory (Fig. 1a). At ﬁrst, the validity of
this rat model was evaluated by analyzing the effects of DPZ, an
acetylcholinesterase inhibitor widely used for the treatment of AD.
Single administration of DPZ (3 mg/kg, p.o.) signiﬁcantly decreased
the number of errors (p < 0.01 by the Scheffe's test), indicating
improvement of spatial memory impairment. Conversely, there wasno signiﬁcant difference in running time in the 8ARMT [mean
running time of sham rats was 139.0 ± 24.9 s, that of vehicle-treated
rats was 215.6 ± 41.4 s and that of DPZ 3 mg/kg-treated rats was
232.2 ± 54.8 s; F (2,35) ¼ 1.131, p ¼ 0.335 by one-way ANOVA].
Effect of DPZ on the decrease in extracellular ACh levels induced by
OVX combined with Ab in the dorsal hippocampus
Fig. 1b shows the time-course of changes in extracellular ACh
levels in the dorsal hippocampus. Two-way repeated ANOVA
revealed a signiﬁcant effect of DPZ (F1,6 ¼ 85.564, p < 0.001), no
200(a)
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Effect of TSS on the impairment of spatial memory induced by OVX
combined with Ab
Repeated administration of TSS (300 mg/kg, p.o.) signiﬁcantly
decreased the number of errors [H3 ¼ 14.671, p < 0.01 by the
KruskaleWallis test; p < 0.05 by the Scheffe's test], indicating
improvement of spatial memory impairment (Fig. 2). Conversely,
there was no signiﬁcant difference in running time in the 8ARMT
[mean running time of sham rats was 123.4 ± 22.8 s, that of vehicle-
treated rats was 133.3 ± 26.2 s, that of TSS 100 mg/kg-treated rats
was 124.9 ± 30.0 s and that of TSS 300 mg/kg-treated rats was
81.2 ± 9.9 s; F (3,39) ¼ 0.942, p ¼ 0.430 by one-way ANOVA].
OVX combined with Ab signiﬁcantly reduced uterus weight
compared with the sham group, yet repeated treatment with TSS
(100 and 300 mg/kg, p.o.) had no effect on the reduction of uterus
weight [mean uterus weight of sham rats was 1.028 ± 0.095 g, that
of vehicle-treated rats was 0.117 ± 0.013 g, that of TSS 100 mg/kg-
treated rats was 0.168 ± 0.048 g and that of TSS 300 mg/kg-treated
rats was 0.131 ± 0.010 g; F (3,37) ¼ 47.019, p < 0.0001 by one-way
ANOVA; vehicle, TSS 100 and 300 mg/kg: p < 0.01 by the
TukeyeKramer post hoc test].β
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#Effect of TSS on the decrease in extracellular ACh levels induced by
OVX combined with Ab in the dorsal hippocampus
OVX combined with Ab signiﬁcantly decreased extracellular
ACh levels at baseline (BL-1 and BL-2) compared with the sham
group, and repeated administration of TSS (300 mg/kg, p.o.) did not
affect the decrease in extracellular ACh levels in the dorsal hippo-
campus [F (2,31)¼ 6.687, p < 0.01 by one-way ANOVA; p < 0.05 and
p < 0.01 by the TukeyeKramer post hoc test; Fig. 3a].
Fig. 3b shows the time-course of changes in extracellular ACh
levels in the dorsal hippocampus. Two-way repeated ANOVA
revealed a signiﬁcant effect of TSS (F1,9 ¼ 7.067, p < 0.05), no
signiﬁcant time difference, and a signiﬁcant TSS  time interaction
(F7,63 ¼ 2.885, p < 0.05).β
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Fig. 2. Effect of TSS on the impairment of spatial memory induced by OVX combined
with Ab (OVX þ Ab) in the eight-arm radial maze test. Ab was injected once daily for 7
days starting 3 weeks after OVX. TSS (100 and 300 mg/kg, p.o.) was administered
immediately after Ab injection for 7 days. The eight-arm radial maze test was carried
out 60 min after the last injection of Ab. The number of correct choices (open bars) and
errors (closed bars) was assessed. Values are the mean ± SEM. *p < 0.05, ***p < 0.001
compared with sham, #p < 0.05 compared with vehicle (Scheffe's test).
Time after TSS injection
Fig. 3. Effect of TSS on the decrease in extracellular ACh levels induced by OVX
combined with Ab (OVX þ Ab) in the dorsal hippocampus. Ab was injected once daily
for 7 days starting 3 weeks after OVX. TSS (300 mg/kg, p.o.) was administered
immediately after Ab injection for 7 days. Extracellular ACh levels were measured in
the dorsal hippocampus of non-anesthetized, freely moving rats by microdialysis on
the seventh day. After a settling period (at least 2e3 h), samples were collected over a
40-min period (baseline, BL-1 and BL-2) before Ab injection and for the following
120 min. (a) Extracellular ACh levels (fmol/mL) at BL-1 and BL-2. Values are the
mean ± SEM. *p < 0.05, **p < 0.01 compared with sham (TukeyeKramer post hoc test).
(b) Time-course of changes in extracellular ACh levels in dialyzates from the dorsal
hippocampus of vehicle- and TSS-treated OVX þ Ab rats. Values are expressed as
percentages (mean ± SEM) of the baseline concentration (BL-1). #p < 0.05 compared
with vehicle (two-way repeated ANOVA).Discussion
In the present study, single administration of DPZ, an acetyl-
cholinesterase inhibitor widely used for the treatment of AD,
improved the impairment of spatial memory and increased
extracellular ACh levels in this model. These results suggest that
DPZ improves the impairment of spatial memory via increasing
extracellular ACh levels.
Similarly, TSS (300 mg/kg, p.o.) could reverse the impairment of
spatial memory induced by OVX combined with Ab in rats. This
N. Egashira et al. / Journal of Pharmacological Sciences 136 (2018) 149e154 153ﬁnding suggests that TSS could attenuate the memory deﬁcits
induced by Ab in postmenopausal women. Conversely, there was
no signiﬁcant difference in running time in the 8ARMT. In addition,
TSS at the same dose had no effect on the reduction of uterus
weight induced by OVX. Therefore, it is unlikely that the amelio-
rative effect of TSS on the impairment of spatial memory can be
attributed to changes in motor activity or estradiol replacement.
Moreover, we investigated involvement of the cholinergic
system in the ameliorative effect of TSS. OVX combined with Ab
decreased extracellular ACh levels at baseline in the dorsal hippo-
campus. This result was consistent with our previous observation.9
Hippocampal cholinergic function has been implicated in learning
and memory.21 Farr and colleagues22 reported that estrogen may
interact with cholinergic function in the hippocampus to modulate
learning and memory. Therefore, one of the causes of impairment
of spatial memory induced by OVX combined with Ab is thought to
be a decrease in extracellular ACh levels in the dorsal hippocampus.
We also found that TSS (300mg/kg, p.o.) did not affect this decrease
in extracellular ACh levels at baseline, whereas TSS administration
at the same dose increased extracellular ACh levels transiently.
These results suggest that TSS increases extracellular ACh levels
transiently rather than preventing the baseline decrease in extra-
cellular ACh levels induced by OVX combined with Ab. Previously,
we reported that single administration of TSS (300 mg/kg, p.o.)
increases extracellular ACh levels in the dorsal hippocampus
in intact rats.20 Results from the present study are essentially
consistent with our previous report. We have also reported that
single administration of TSS improves scopolamine-induced
impairment of spatial memory in rats.14 Furthermore, we have re-
ported that single administration of TSS enhances tremors induced
by the muscarinic M1 receptor agonist oxotremorine.23 These
tremors are antagonized completely by scopolamine hydrobromide
but not by the peripheral muscarinic receptor antagonist scopol-
amine methyl bromide,24 suggesting that tremor enhancement is
induced by increasing central cholinergic activity. Hence, TSS may
ameliorate the impairment of spatial memory by enhancing the
activity of cholinergic neurons.
We investigated the effects of various components and fractions
of TSS on scopolamine-induced impairment of spatial memory in
the 8ARMT in rats. We found that Toki, a medicinal herb in TSS, was
the most effective among its component herbs.25 Moreover,
investigation of the effects of fractions isolated from Toki revealed
that its activity is mainly resided in the butanol layer and its con-
tents of 1,2,3,4-tetrahydro-b-carboline-3-carboxylic acid (Ang-S-1),
which is similar to the structure of N-methyl-b-carboline-3-car-
boxamide (FG7142). A partial inverse agonist of benzodiazepine,
FG7142, improved scopolamine-induced memory deﬁcits in the
same test,25 and could indirectly increase the mnemonic function
of cholinergic neurons by reducing gamma-aminobutyric acid
(GABA)ergic inhibition. Taken together with these ﬁndings, our
studies suggest that Ang-S-1 is an active compound of TSS that can
improve impairment of spatial memory, and that its mechanism of
action involves enhancement of cholinergic function. Hence, TSS
may increase extracellular ACh levels through benzodiazepine re-
ceptors. TSS has also been reported to suppress the decrease of
choline acetyltransferase (ChAT) activity in the cerebral cortex and
the dorsal hippocampus of OVX mice.26 Therefore, suppression of
decreased ChAT activity might also be involved in the increase of
extracellular ACh levels.
In conclusion, TSS improved not only the impairment of spatial
memory induced by OVX combined with Ab, but also the decrease
in extracellular ACh levels in the dorsal hippocampus. Our data
suggest that the ameliorative effect of TSS on the impairment of
spatial memory is mediated (at least in part) by enhancing
cholinergic activity in the dorsal hippocampus. Therefore, TSS maybe useful for the treatment of memory deﬁcits induced by Ab, such
as AD in postmenopausal women.
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